← Leaderboards
Subramaniam Ananthan
Southern Research Institute
$10,843,209
Attributed
$10,843,209
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2005–19$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$10,843,209 · 6
By mechanism
R01$8,077,146 · 3
R33$1,161,036 · 1
R21$756,894 · 1
N01$613,268 · 1
N02$234,865 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroLigandsLeadEvaluationDesignPharmaceutical PreparationsBaseBrainAddictionIn VivoDrug KineticsStructurePenetrationReceptorComputer SimulationProtocols DocumentationRadioligandBiological AvailabilityPropertyRattusOpioid ReceptorPharmaceutical ChemistryBinding (Molecular Function)Agonist
Grant awards (25)
Opioid Ligands for the treatment of Alzheimer's Disease (Administrative Supplement on Parent Grant R01DA038635)$527,409
R01 · FY2019 · DA · contact PI
Development of Mu Agonist Delta Antagonist Opioids as Analgesics for Chronic Pain$892,417
R01 · FY2018 · DA · contact PI
Development of Mu Agonist Delta Antagonist Opioids as Analgesics for Chronic Pain$882,231
R01 · FY2017 · DA · contact PI
TASK E07: CENTRAL DATA MANAGEMENT CENTER CUSTOMIZATION AND MAINTENANCE$146,762
N01 · FY2017 · AI · contact PI
Development of Mu Agonist Delta Antagonist Opioids as Analgesics for Chronic Pain$879,889
R01 · FY2016 · DA · contact PI
In Vitro Assessments Program Central Data Management Center$125,561
N01 · FY2016 · AI · contact PI
Development of Mu Agonist Delta Antagonist Opioids as Analgesics for Chronic Pain$912,586
R01 · FY2015 · DA · contact PI
Task Order E05: In Vitro Testing Central Data Management Center$315,945
N01 · FY2015 · AI · contact PI
Targeted Library Synthesis and Screening: Allosteric Modulators of Transporters$388,748
R33 · FY2014 · DA · contact PI
Task E04: Central Data Management Center$234,865
N02 · FY2014 · AI · contact PI
Targeted Library Synthesis and Screening: Allosteric Modulators of Transporters$376,014
R33 · FY2013 · DA · contact PI
Targeted Library Synthesis and Screening: Allosteric Modulators of Transporters$396,274
R33 · FY2012 · DA · contact PI
Development of Dopamine D3 Ligands as Medications for Psychostimulant Addiction$464,065
R01 · FY2011 · DA · contact PI
Targeted Library Synthesis and Screening: Allosteric Modulators of Transporters$374,408
R21 · FY2011 · DA · contact PI
In Vitro Assessments for Antimicrobial Activity$25,000
N01 · FY2011 · AI · contact PI
Development of Dopamine D3 Ligands as Medications for Psychostimulant Addiction$476,321
R01 · FY2010 · DA · contact PI
Targeted Library Synthesis and Screening: Allosteric Modulators of Transporters$382,486
R21 · FY2010 · DA · contact PI
Development of Dopamine D3 Ligands as Medications for Psychostimulant Addiction$478,187
R01 · FY2009 · DA · contact PI
Novel Nonpeptide Ligands for the Opioid Receptors$393,207
R01 · FY2007 · DA · contact PI
Novel Nonpeptide Ligands for the Opioid Receptors$410,044
R01 · FY2006 · DA · contact PI
Novel Nonpeptide Ligands for the Opioid Receptors$447,534
R01 · FY2005 · DA
NOVEL NONPEPTIDE LIGANDS FOR THE OPIOID RECEPTORS$460,766
R01 · FY2002 · DA
NOVEL NONPEPTIDE LIGANDS FOR THE OPIOID RECEPTORS$391,724
R01 · FY2001 · DA
NOVEL NONPEPTIDE LIGANDS FOR THE OPIOID RECEPTORS$69,042
R01 · FY2001 · DA
NOVEL NONPEPTIDE LIGANDS FOR THE OPIOID RECEPTORS$391,724
R01 · FY2000 · DA